Howard Edelman's Contact Details

Howard Edelman's Company Details

Advanced Resin Therapeutics is a specialty pharmaceutical company that has developed a novel, resin-based, drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies. The company has grown its IP portfolio to include 11 issued patents worldwide and 28 pending patents. Clinical trial results confirm quick, safe, and prolonged delivery of medications for both its topical and transmucosal product lines. Since its inception, the Company has brought in $5M in licensing revenue, and now has two market-ready products and two clinical stage products. In addition, the company has distribution agreements in place for its post-operative topical product (Mastisol® Plus) in the U.S. surgical adhesive marketplace. ART's lead product opportunity is NicoSwab™, a highly innovative, fast-acting, long-lasting nicotine replacement product.